Analystreport

Teva Pharmaceutical Industries Limited (NYSE: TEVA) had its price target lowered by analysts at Royal Bank Of Canada from $21.00 to $15.00. They now have an "underperform" rating on the st...

Teva Pharmaceutical Industries Limited American Depositary Shares  (TEVA) 
Last teva pharmaceutical industries limited american depositary shares earnings: 2/13 04:01 pm Check Earnings Report
US:NYSE Investor Relations: ir.tevapharm.com